Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Other Working Capital Changes (2022 - 2025)

Envoy Medical's Other Working Capital Changes history spans 4 years, with the latest figure at $118000.0 for Q3 2025.

  • For Q3 2025, Other Working Capital Changes rose 229.01% year-over-year to $118000.0; the TTM value through Sep 2025 reached $616000.0, up 1617.55%, while the annual FY2024 figure was -$9000.0, 92.97% up from the prior year.
  • Other Working Capital Changes for Q3 2025 was $118000.0 at Envoy Medical, up from -$119000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $703000.0 in Q3 2023 and bottomed at -$996000.0 in Q4 2023.
  • The 4-year median for Other Working Capital Changes is $35865.0 (2024), against an average of $31524.3.
  • The largest YoY upside for Other Working Capital Changes was 5396.05% in 2023 against a maximum downside of 4430.43% in 2023.
  • A 4-year view of Other Working Capital Changes shows it stood at $23000.0 in 2022, then tumbled by 4430.43% to -$996000.0 in 2023, then soared by 154.42% to $542000.0 in 2024, then plummeted by 78.23% to $118000.0 in 2025.
  • Per Business Quant, the three most recent readings for COCH's Other Working Capital Changes are $118000.0 (Q3 2025), -$119000.0 (Q2 2025), and $75000.0 (Q1 2025).